Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.

MedStar author(s):
Citation: Pharmacogenomics. 21(15):1085-1094, 2020 10.PMID: 32969759Institution: MedStar Medical GroupDepartment: Assistant Vice President | Associate Dean for Research Development | MedStar Center for Successful Aging | MedStar Health | Pharmacogenomics | Vice PresidentForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Attitude of Health Personnel | *Health Personnel/px [Psychology] | *Pharmacogenomic Testing/mt [Methods] | *Primary Health Care/mt [Methods] | *Surveys and Questionnaires | Female | Humans | Male | Nurse Practitioners/px [Psychology] | Pharmacogenetics/mt [Methods] | Physician Assistants/px [Psychology] | Physicians, Primary Care/px [Psychology] | Precision Medicine/px [Psychology]Year: 2020ISSN:
  • 1462-2416
Name of journal: PharmacogenomicsAbstract: Aims: Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed and then disseminated to PCPs across the MedStar Health System. Results: Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (84%) had heard of PGx and 12 (13%) previously ordered PGx testing. Most, 68 (76%), believed PGx can improve care; however, a minority, 23 (26%), reported confidence in using PGx in prescribing decisions. Sixty-four (70%) wanted a pharmacist consultation. PCPs desired PGx for antidepressants (75%), proton pump inhibitors (72%) and other medications. Conclusion: Most PCPs felt unprepared to interpret PGx results and desired pharmacist consultations. These data can inform future PGx implementations with PCPs.All authors: Brandt N, Brown RP, Levin B, Namvar T, Peshkin BN, Smith DM, Springfield TB, Swain SM, Walsh RJ, Welsh JCOriginally published: Pharmacogenomics. 2020 Sep 24Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2020-10-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32969759 Available 32969759

Aims: Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed and then disseminated to PCPs across the MedStar Health System. Results: Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (84%) had heard of PGx and 12 (13%) previously ordered PGx testing. Most, 68 (76%), believed PGx can improve care; however, a minority, 23 (26%), reported confidence in using PGx in prescribing decisions. Sixty-four (70%) wanted a pharmacist consultation. PCPs desired PGx for antidepressants (75%), proton pump inhibitors (72%) and other medications. Conclusion: Most PCPs felt unprepared to interpret PGx results and desired pharmacist consultations. These data can inform future PGx implementations with PCPs.

English

Powered by Koha